Literature DB >> 28202542

Mössbauer Spectra of Mouse Hearts Reveal Age-dependent Changes in Mitochondrial and Ferritin Iron Levels.

Joshua D Wofford1, Mrinmoy Chakrabarti1, Paul A Lindahl2,3.   

Abstract

Cardiac function requires continuous high levels of energy, and so iron, a critical player in mitochondrial respiration, is an important component of the heart. Hearts from 57Fe-enriched mice were evaluated by Mössbauer spectroscopy. Spectra consisted of a sextet and two quadrupole doublets. One doublet was due to residual blood, whereas the other was due to [Fe4S4]2+ clusters and low-spin FeII hemes, most of which were associated with mitochondrial respiration. The sextet was due to ferritin; there was no evidence of hemosiderin, a ferritin decomposition product. Iron from ferritin was nearly absent in young hearts, but increased steadily with age. EPR spectra exhibited signals similar to those of brain, liver, and human cells. No age-dependent EPR trends were apparent. Hearts from HFE-/- mice with hemochromatosis contained slightly more iron overall than controls, including more ferritin and less mitochondrial iron; these differences typify slightly older hearts, perhaps reflecting the burden due to this disease. HFE-/- livers were overloaded with ferritin but had low mitochondrial iron levels. IRP2-/- hearts contained less ferritin than controls but normal levels of mitochondrial iron. Hearts of young mice born to an iron-deficient mother contained normal levels of mitochondrial iron and no ferritin; the heart from the mother contained low ferritin and normal levels of mitochondrial iron. High-spin FeII ions were nearly undetectable in heart samples; these were evident in brains, livers, and human cells. Previous Mössbauer spectra of unenriched diseased human hearts lacked mitochondrial and blood doublets and included hemosiderin features. This suggests degradation of iron-containing species during sample preparation.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  Mossbauer spectroscopy; cardiac metabolism; electron paramagnetic resonance (EPR); iron; mitochondria

Mesh:

Substances:

Year:  2017        PMID: 28202542      PMCID: PMC5392696          DOI: 10.1074/jbc.M117.777201

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Proteomic analysis of hearts from frataxin knockout mice: marked rearrangement of energy metabolism, a response to cellular stress and altered expression of proteins involved in cell structure, motility and metabolism.

Authors:  Robert Sutak; Xiangcong Xu; Megan Whitnall; Mohammed Abul Kashem; Daniel Vyoral; Des R Richardson
Journal:  Proteomics       Date:  2008-04       Impact factor: 3.984

2.  Hemochromatosis and pregnancy: iron stores in the Hfe-/- mouse are not reduced by multiple pregnancies.

Authors:  João Vilares Neves; Ingrid Anna Sofia Olsson; Graça Porto; Pedro Nuno Rodrigues
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-01-28       Impact factor: 4.052

3.  Minihepcidins prevent iron overload in a hepcidin-deficient mouse model of severe hemochromatosis.

Authors:  Emilio Ramos; Piotr Ruchala; Julia B Goodnough; Léon Kautz; Gloria C Preza; Elizabeta Nemeth; Tomas Ganz
Journal:  Blood       Date:  2012-09-18       Impact factor: 22.113

4.  Iron and iron-responsive proteins in the cardiomyopathy of Friedreich's ataxia.

Authors:  Susan Michael; Simone V Petrocine; Jiang Qian; Jacques B Lamarche; Mitchell D Knutson; Michael D Garrick; Arnulf H Koeppen
Journal:  Cerebellum       Date:  2006       Impact factor: 3.847

5.  Myocardial iron metabolism in the regulation of cardiovascular diseases in rats.

Authors:  Na Zhao; Zhidan Sun; Yuying Mao; Pengzhou Hang; Xing Jiang; Lihua Sun; Jinlong Zhao; Zhimin Du
Journal:  Cell Physiol Biochem       Date:  2010-05-18

6.  ZIP14 and DMT1 in the liver, pancreas, and heart are differentially regulated by iron deficiency and overload: implications for tissue iron uptake in iron-related disorders.

Authors:  Hyeyoung Nam; Chia-Yu Wang; Lin Zhang; Wei Zhang; Shintaro Hojyo; Toshiyuki Fukada; Mitchell D Knutson
Journal:  Haematologica       Date:  2013-01-24       Impact factor: 9.941

7.  59Fe-distribution in conditional ferritin-H-deleted mice.

Authors:  Martin Kistler; Anna Even; Stefan Wagner; Christiane Becker; Depak Darshan; Liviu Vanoaica; Lucas C Kühn; Klaus Schümann
Journal:  Exp Hematol       Date:  2013-10-17       Impact factor: 3.084

8.  Prevention and reversal of severe mitochondrial cardiomyopathy by gene therapy in a mouse model of Friedreich's ataxia.

Authors:  Morgane Perdomini; Brahim Belbellaa; Laurent Monassier; Laurence Reutenauer; Nadia Messaddeq; Nathalie Cartier; Ronald G Crystal; Patrick Aubourg; Hélène Puccio
Journal:  Nat Med       Date:  2014-04-06       Impact factor: 53.440

9.  Mitochondrial ferritin expression in adult mouse tissues.

Authors:  Paolo Santambrogio; Giorgio Biasiotto; Francesca Sanvito; Stefano Olivieri; Paolo Arosio; Sonia Levi
Journal:  J Histochem Cytochem       Date:  2007-07-11       Impact factor: 2.479

10.  Abnormal brain iron metabolism in Irp2 deficient mice is associated with mild neurological and behavioral impairments.

Authors:  Kimberly B Zumbrennen-Bullough; Lore Becker; Lillian Garrett; Sabine M Hölter; Julia Calzada-Wack; Ilona Mossbrugger; Leticia Quintanilla-Fend; Ildiko Racz; Birgit Rathkolb; Thomas Klopstock; Wolfgang Wurst; Andreas Zimmer; Eckhard Wolf; Helmut Fuchs; Valerie Gailus-Durner; Martin Hrabě de Angelis; Steven J Romney; Elizabeth A Leibold
Journal:  PLoS One       Date:  2014-06-04       Impact factor: 3.240

View more
  6 in total

Review 1.  Conservative iron chelation for neurodegenerative diseases such as Parkinson's disease and amyotrophic lateral sclerosis.

Authors:  David Devos; Z Ioav Cabantchik; Caroline Moreau; Véronique Danel; Laura Mahoney-Sanchez; Hind Bouchaoui; Flore Gouel; Anne-Sophie Rolland; James A Duce; Jean-Christophe Devedjian
Journal:  J Neural Transm (Vienna)       Date:  2020-01-07       Impact factor: 3.575

Review 2.  Iron Deficiency as a Therapeutic Target in Cardiovascular Disease.

Authors:  Samira Lakhal-Littleton
Journal:  Pharmaceuticals (Basel)       Date:  2019-08-28

3.  circSnx12 Is Involved in Ferroptosis During Heart Failure by Targeting miR-224-5p.

Authors:  Haoyuan Zheng; Lin Shi; Changci Tong; Yunen Liu; Mingxiao Hou
Journal:  Front Cardiovasc Med       Date:  2021-04-21

Review 4.  A Novel Insight Into the Fate of Cardiomyocytes in Ischemia-Reperfusion Injury: From Iron Metabolism to Ferroptosis.

Authors:  Jing-Yan Li; Shuang-Qing Liu; Ren-Qi Yao; Ying-Ping Tian; Yong-Ming Yao
Journal:  Front Cell Dev Biol       Date:  2021-12-02

Review 5.  Mechanisms of cardiac iron homeostasis and their importance to heart function.

Authors:  Samira Lakhal-Littleton
Journal:  Free Radic Biol Med       Date:  2018-08-11       Impact factor: 7.376

Review 6.  The Molecular Mechanisms of Iron Metabolism and Its Role in Cardiac Dysfunction and Cardioprotection.

Authors:  Tanya Ravingerová; Lucia Kindernay; Monika Barteková; Miroslav Ferko; Adriana Adameová; Vladislava Zohdi; Iveta Bernátová; Kristina Ferenczyová; Antigone Lazou
Journal:  Int J Mol Sci       Date:  2020-10-24       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.